Vevo 3100
The Ultimate Preclinical Imaging Experience
The World's 1st One-Touch Preclinical Imaging Platform
The Vevo 3100 Imaging System helps you visualize your data at high resolution like never before.
Vessel walls appear sharp, pre-palpable lesions are clearly delineated, and rib shadows are reduced.
With a powerful combination of high frame rates and advanced image processing, the Vevo 3100 micro-ultrasound imaging system reduces speckle noise and artifacts while preserving and enhancing critical information for small animal in vivo studies.
Benefits
- Vevo HD - Visualize your data like never before
- Intuitive touchscreen interface for all user types
- Customizable workflow for rapid data acquisition
- Anatomical, hemodynamic, functional, and molecular data all in one platform
- Compact, maneuverable system
- Hands-free scanning using Vevo Voice
- State-of-the-art Ultra High Frequency - up to 70 MHz
- Photoacoustic imaging using the LAZR-X cart
- Resolution down to 30 µm
The unique, gesture-driven user interface can be personalized by each user and is easily controlled with the glide of a finger - no keys or buttons. Customization of workflow drives rapid data acquisition, providing extremely high-throughput.
In vivo imaging has never been easier!
 |
Vevo LABAnalyze your high-frequency ultrasound and photoacoustic imaging data quickly and efficiently! |
What applications are possible with the Vevo 3100? Explore the possibilities in...
ONCOLOGY
- Tumor detection and sizing in 2D and 3D
- Vascularity and perfusion
- Tumor model characterization
- Response to therapy
DEVELOPMENTAL
- Placental structure and function
- Pregnancy screening
- Embryo injections
CARDIOVASCULAR
- Cardiac function in 2D, 3D and 4D
- Hemodynamics
- Myocardial and vascular strain
- Cardiotoxicity
Featured applications related to the The World's 1st One-Touch Preclinical Imaging Platform
See below publications related to the The World's 1st One-Touch Preclinical Imaging Platform. For more publications, please browse specific application.
PM2.5-induced ADRB2 hypermethylation contributed to cardiac dysfunction through cardiomyocytes apoptosis via PI3K/Akt pathway
Size-dependent Tumor Response to Photodynamic Therapy and Irinotecan Monotherapies Revealed by Longitudinal Ultrasound Monitoring in an Orthotopic Pancreatic Cancer Model
A preclinical ultrasound method for the assessment of vascular disease progression in murine models
Immune response mediates cardiac dysfunction after traumatic brain injury
Optimal range of injection rates for a lymphatic drug delivery system
